Parallel Bio

Drug Discovery · Cambridge, MA · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to design and engineer tools to change the way diseases are cured. Parallel Bio is based in Cambridge, MA and was founded in 2020. It was valued at $71.5 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $24.6 million across 2 recorded rounds; the latest was a $20 million Series A1 in Jun 2025.

PMV mark · valuation
$71.5M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$24.6M
Last round
Later Stage VC (Series A1)
Jun 2025

Who backs Parallel Bio?

24 investors
InvestorType
Y CombinatorOther
GaingelsVenture capital
Metaplanet HoldingsVenture capital
Asymmetry VenturesVenture capital
Jeff DeanOther
Spacecadet VenturesVenture capital
AIX VenturesVenture capital
Refactor CapitalVenture capital
Marc Benioff—
Humba VenturesVenture capital
+ 14 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Parallel Bio investors

24 investors are on record for Parallel Bio, including Y Combinator, Gaingels, Metaplanet Holdings and Asymmetry Ventures. By type, the record holds 7 venture capital firms and 1 family office. The Series A1 in Jun 2025 drew 7 investors.

Free account
More of Parallel Bio with a free account
  • ·The complete investor list: 24 names
  • ·Watch Parallel Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 24 firms already write checks for companies like Parallel Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View